0000899243-21-036298.txt : 20210916 0000899243-21-036298.hdr.sgml : 20210916 20210916173813 ACCESSION NUMBER: 0000899243-21-036298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210914 FILED AS OF DATE: 20210916 DATE AS OF CHANGE: 20210916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kushner Joshua CENTRAL INDEX KEY: 0001844181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40154 FILM NUMBER: 211258761 MAIL ADDRESS: STREET 1: C/O OSCAR HEALTH, INC. STREET 2: 75 VARICK STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oscar Health, Inc. CENTRAL INDEX KEY: 0001568651 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 403-3677 MAIL ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: Mulberry Health Inc. DATE OF NAME CHANGE: 20130204 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-14 0 0001568651 Oscar Health, Inc. OSCR 0001844181 Kushner Joshua 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 1 1 1 0 Co-Founder and Vice Chairman Class A Common Stock 2021-09-14 4 P 0 515344 18.097 A 4431497 I See footnote Class A Common Stock 2021-09-15 4 P 0 323725 17.855 A 4755222 I See footnote Represents (i) 509,209 shares purchased by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and (ii) 6,135 shares purchased by Claremount VII Associates, L.P. ("Claremount VII"). The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.685 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 4,378,741 shares are held directly by Thrive VII Growth and 52,756 shares are held directly by Claremount VII. Shares held directly by Thrive VII Growth and Claremount VII. Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII and Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of each of Thrive Partners VII Growth and Thrive Partners VII, and, in his capacity as managing member, has voting and investment power over the shares held by each of Thrive VII Growth and Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by the Thrive VII Growth and Claremount VII except to the extent of their pecuniary interest therein. Represents (i) 319,871 shares purchased by Thrive VII Growth and (ii) 3,854 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.62 to $18.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 4,698,612 shares are held directly by Thrive VII Growth and 56,610 shares are held directly by Claremount VII. /s/ Joshua Kushner 2021-09-16